Inclusion of clinical opinions in economic evaluations
fre. 14. okt.
|Kreftforeningens vitensenter / Streaming
This CONNECT seminar is about "Inclusion of clinical opinions in economic evaluations: From theory to practice"
Time & Location
14. okt. 2022, 11:30 – 13:45
Kreftforeningens vitensenter / Streaming, Kongens gate 6, 0153 Oslo, Norway
About the event
Welcome to the CONNECT Seminar:
Inclusion of clinical opinions in economic evaluations: From theory to practice
Host: CONNECT Working Group 3
Date: Friday, October 14th, 2022; 11:30h – 13:45h (CET)
Venue: Kreftforeningens Vitensenter, with opportunity to join digitally.
Register for in-person attendance here: https://kurs.kreftforeningen.no/inkludering-av-kliniske-ekspertvurderinger-i-metodevurderinger-fra-teori-til-praksis-2022042 (Please note. Registration is only for in-person/on-site attendance.)
Streaming here: https://livestream.kreftforeningen.no
AGENDA
Part 1: Inclusion of clinical opinions in economic evaluations - From theory to practice
11:30 – 12:00 Arrival and coffee for on-site participants // Log-in for digital participation
12:00 – 12:05 Welcome and Introduction
Eline Aas, Førsteamanuensis, Department of Health Management and Health Economics, University of Oslo; CONNECT WG3 Lead
12:05 – 12:40 Case Methods for Expert Elicitation in Health Care Decision Making
Professor Laura Bojke, Team Leader for Economic Evaluation & Health Technology Assessment; Health Economics, Evaluation & Equality (HEEE) theme lead, Centre for Health Economics, University of York
12:40 – 13:00 Reducing uncertainty surrounding cost-effectiveness of precision cancer medicine by including expert opinions
Magnus Bangum, Former master’s student at the Department of Health Management and Health Economics, University of Oslo
Part 2: Panel discussion – Future use of systematic implementation of clinical opinions
(This part will be in Norwegian)
13:00 – 13:45 Panelsamtale: Fremtidig systematisk bruk av klinikere
Moderator: Petter Foss, International Value and Access Partner Solid Tumors, Europe, Novartis Oncology
Jan Frich, Viseadministrerende direktør og Fagdirektør, Helse Sør-Øst RHF
Eline Aas, Professor, Department og Health Management and Health Economics, University of Oslo; CONNECT WG3 Lead
Magnus Bangum, Former master’s student at the Department of Health Management and Health Economics, University of Oslo
Fredrik Schjesvold, Head of Oslo Myeloma Center at Oslo University Hospital
Halfdan Sørbye, Overlege, Professor, Kreftavdelingen, Haukeland Universitetssykehus
Bente Kristin Johansen fra Legeforeningen
Kristin Svanqvist, Head of Governmental Affairs and Communication, Merck Norway
Contact: Jutta Heix, Head of International Affairs Oslo Cancer Cluster / Project Lead CONNECT; jh@oslocancercluster.no